News
Why self-management is key to a better life for heart failure patients
Putting patients at the heart of heart failure services
British IRONMAN Trial Published
MPs more interested in potholes than heart failure
Empagliflozin
UK Heart Failure Patient Charter
Living well with Heart Failure report 2022
DAPAGLIFLOZIN ACCEPTED FOR USE WITHIN NHS SCOTLAND
Legal right to 2 week review of patients with suspected heart failure (HF)
NICE Impact Report Cardiovascular Disease Management
NICE Recommends Dapagliflozin for Heart Failure
NICE in the UK recommends Dapagliflozin (FORXIGA) to treat heart failure with reduced ejection fraction for patients with or without Diabetes.
Heart failure and Covid-19 Statement
Heart Failure Marvellous Award Winners 2021 for their outstanding contribution
